HAISHUN(SZ:300501)2025-05-16 09:42Group 1: Financial Performance - The net profit attributable to shareholders decreased by 58.47% year-on-year, from over 21 million to over 9 million [1] - The decline in net profit was primarily due to depreciation from the completion of a high-barrier composite material project and the implementation of an employee stock ownership plan, impacting profits by over 6 million and over 3 million respectively [1][2] Group 2: Strategic Initiatives - The company aims to enhance performance through cost reduction, efficiency improvement, and increased R&D and market expansion efforts [2] - Future plans include strengthening information disclosure and investor communication while focusing on share repurchase and employee stock ownership initiatives [2] Group 3: Development Focus - The company is prioritizing the completion of its private placement and convertible bond projects to support future growth [3] - External growth through mergers and acquisitions is considered, but the company emphasizes the importance of technological and market synergies [3] Group 4: Product Development - A new division for high-performance medical film materials has been established, focusing on ostomy pouch films and high-end infusion films, with the latter being reliant on imports [3][4] - The company is also developing electronic materials, including UV adhesive tapes and PI high-temperature adhesive tapes, with some products already passing tests by downstream manufacturers [4] Group 5: Market Outlook - The aluminum-plastic film market is expected to grow significantly with the industrialization of solid-state batteries, with the company working on client certifications before market expansion [4] - The company has improved its thermal process technology for aluminum-plastic films and is preparing samples for clients [4]